Medicine & Health Sciences

The Role of Probiotics in Cancer Management
Editors: Md. Faiyazuddin, PhD
Sumel Ashique

The Role of Probiotics in Cancer Management

In Production
Pub Date: Forthcoming December 2024
Hardback Price: $249 US | £200 UK
Hard ISBN: 9781774919125
Pages: Est. 615pp w/index
Binding Type: Hardback / ebook
Notes: 14 color and 28 b/w illustrations

This new book explores the latest advances in probiotic research, focusing on the effectiveness of probiotics in preventing cancer and supporting the treatment of cancer. Probiotics have gained increased medical significance due to their beneficial effect on the human body that includes the prevention of disease and support of the treatment of many diseases along with their absence of side effects. This volume examines the evidence that the use of probiotics can play an important role in cancer prevention and support anti-cancer therapies.

The volume first provides an introduction to prebiotics, probiotics, and synbiotics, covering the anticancer properties of probiotic microorganisms, the impact of their metabolites, the potential mechanisms of probiotic chemoprevention, and the feasibility of incorporating probiotics into cancer care strategies. The volume looks at studies that examine the efficacy of probiotics in the treatment and management of such cancers as bladder cancer, colorectal cancer, cervical cancers, lung cancer, brain cancer, and others. It takes an in-depth look at gut microbiota and the role of probiotics as immune boosters and also considers possible toxicology challenges of probiotics as well.

The Role of Probiotics in Cancer Management will be a valuable resource for academics and research and industry professionals working in the field of gut microbiota, probiotics, and nutraceuticals who have a special focus on cancer management.

CONTENTS:
Preface

Introduction to Prebiotics, Probiotics, and Synbiotics

Sumel Ashique and Md. Faiyazuddin

1. Probiotics and Their Potential Effects on Cancer Management
Garima Sahu, Alok Mukerjee, Sumel Ashique, and Himanshu Sharma

2. Probiotics as a Promising Candidate for the Management of Colorectal Cancer
Devesh U. Kapoor, Madan Mohan Gupta, Deblina Pal, and Deepak Sharma

3. Correlation Between Gut Microbiota and Cancer
Rashmi Pathak and Himanshu Sharma

4. Importance of Probiotics in Gut Microbiota for the Management of Cancer
Priyanka Ray, Saini Setua, and Debojyoti Adak

5. Role of Prebiotics and Probiotics in Protection against Cervical Cancers
Subhrojyoti Ghosh, Anuvab Dey, Nirmal Sarkar, Sourav Majhi, Suman Barua, Aishi Bera, and Subhranil Hazra

6. Probiotics for the Mitigation of Inflammation-Based Lung Cancer
Rakesh Das, Sourav Ghosh, and Ayan Chatterjee

7. Importance of Synbiotics for the Management of Colorectal Cancers
Abhishek Kanugo, Satish Polshettiwar, and Rupesh K. Gautam

8. Correlation Between Reactive Oxygen Species (ROS), Inflammation, and Probiotics
Vijayaraj Surendran, Monika Kaushik, Prathap Madeswaraguptha, and Ponnusamy Rajavel

9. Probiotics: The Nonpathogenic Microorganisms with a Functional Role in Bladder Cancer Management
Sumel Ashique, Subhra Prakash Bhattacharyya, Indrani Bhattacharyya, Shubneesh Kumar, Subhajit Mandal, Mansi Singh, Sanjesh Kumar, Krishnendu Adhikary, Pooja S. Murkute, Farzad Taghizadeh-Hesary, Ushasi Das, Arshad Farid, and Mohammad Houshyari

10. Immune System Modulation by Probiotics: An Account of Brain Cancers
Shruti Ghumra, Anmol Seelan, Aarya Pulkundwar, Sourav Mohanto, Vino Sundararajan, and Sagnik Nag

11. Functional Role of Probiotics in Cancer Prevention and Treatment as Well as Their Role as Immune Boosters
Biswajit Das, Somya Ranjan Dash, Saptarshi Sinha, and Chanakya Nath Kundu

12. Toxicology of Probiotics: Challenges and Future Prospects
Ushasi Das, Ravinder Kumar Mehra, Subhajit Mandal, Sumel Ashique, Shubneesh Kumar, Arshad Farid, Afzal Hussain, Neeraj Mishra, Md. Faiyazuddin, and Farzad Taghizadeh-Hesary

13. Impact of SARS-CoV-2 on Cancer Patients and the Role of Probiotics for Management and to Boost the Immune System
Arshad Farid, Sana Fatima, Sohail Ahmad, Muhammad Muzammal, and Fazal Haq

Index


About the Authors / Editors:
Editors: Md. Faiyazuddin, PhD
Professor of Pharmaceutics and Founder Dean, Research & Development, Al-Karim University, School of Pharmacy, Katihar, Bihar, India

Md. Faiyazuddin, PhD, is a distinguished academician and researcher with extensive experience in working across government, public, and private sectors. He has 17 years of experience in pharmacy teaching, drug development, research consultation, and social pharmacy outreach activities in academia and industry. He is currently a Professor of Pharmaceutics and Founder Dean, Research & Development at Al-Karim University, School of Pharmacy, Katihar, Bihar, India. Prior to this, he was the Dean and Professor of Pharmaceutics at The R. C. University India (2019–2021), Principal and Professor of Pharmaceutics/Drug Delivery at Bihar College of Pharmacy (2016–2019), Assistant Professor and Quality coordinator at University of Hail, KSA (2014–2016) and Assistant Professor and Chief Investigator at the Nano Drug Delivery Research Laboratory at the Integral University, India (2007–2014). He is a visiting scientist and adjunct professor at reputed universities at national as well as international levels, sharing outstanding ideas and cutting-edge technologies with laureates in health and the pharmaceutical sectors. He was awarded a prestigious DST Young Scientist Award by the Govt. of India to pursue a research in cancer nanotechnology. Holding a PhD in Pharmaceutics from Jamia Hamdard, New Delhi, India, Dr. Faiyazuddin specializes in pharmaceutical nanotechnology and earned an executive strategic leadership management degree at the Jacobs-Abbey Global Institute for Leadership Studies, Woodbridge, Virginia, USA. He has extensive research experience in pharmaceutical nanotechnology, advanced drug delivery, and marine bioactives and, recently, pharmaceutical AI and probiotics medicines. This is reflected by his authorship of more than 105 published papers (in ACS, Elsevier, Wiley, Bentham, RSC, and Frontier Q1 journals), nine issued patents and patent applications, 12 books, 48 book chapters, eight awards, seven fellowships, member of 13 editorial boards, and conference chair and more than 50 invited conference presentations. Dr. Faiyazuddin is a member of many prominent professional organizations, including the Institute of Nanotechnology, Sterling University, Scotland; the British Society of Nanomedicine; the University of Liverpool UK; the International Society of Aerosol in Medicine; and the American Lung Association, USA. Dr Faiyazuddin has secured multiple major federal and non-federal research grants and has successfully completed research grants from various R&D agencies, including SERB-DST and foreign agencies. Outside his day job, Dr. Faiyazuddin has a keen interest in connecting worldwide researchers to practice safe drugs under the flagship of the International Pharmaceutical Forum.

Sumel Ashique
Assistant Professor, Bengal College of Pharmaceutical Sciences & Research, Durgapur, West Bengal, India

Sumel Ashique has been working as an Assistant Professor at Bengal College of Pharmaceutical Science and Research, Durgapur, West Bengal, India. He has four years of teaching experience. He has published 80 publications in international and national accredited reputed journals. He has knowledge in drug delivery, nanotechnology, and targeted treatment strategy. He is working as a potential reviewer for many reputed publishers (Elsevier, Springer, Dove Press, Bentham Sc.). He has also five granted patents from IP and Australia as a well as 20 published chapters in books from Bentham, Springer, Elsevier, Bentham and Taylor & Francis. Currently he is editing eight books under CRC Press, Taylor and Francis, Wiley, Nova Science, and Springer.




Follow us for the latest from Apple Academic Press:
Copyright © 2024 Apple Academic Press Inc. All Rights Reserved.